Science Explorer Interactive view Map

Amoebic Infections and Treatments

Amoebic Infections and Treatments is a research topic within Infectious Diseases. Science Explorer counts 22k research works in it since 1950. 10.6% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pathogenesis, clinical management, diagnosis, and treatment of amoebiasis, with a specific emphasis on Entamoeba histolytica infections and pyogenic liver abscesses. It covers topics such as laboratory diagnosis techniques, cysteine proteases involved in pathogenesis, epidemiology, percutaneous drainage, and the host immune response to the infection.

  • Entamoeba histolytica
  • pyogenic liver abscess
  • diagnosis
  • treatment
  • pathogenesis
  • laboratory diagnosis
  • cysteine proteases
  • epidemiology
  • percutaneous drainage
  • immune response
Research works
22k
fractional, since 1950
In the world top 10%
2.3k
per year above
Top-10% rate
10.6%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+15%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Amoebic Infections and Treatments research?

By volume, the United States and China publish the most (427 and 402 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 427 works
  2. 2 China 402 works
  3. 3 India 290 works
  4. 4 Japan 126 works
  5. 5 Türkiye 110 works
  6. 6 Iraq 107 works
  7. 7 United Kingdom 97 works
  8. 8 Iran 81 works
  9. 9 Germany 80 works
  10. 10 Brazil 76 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 23.8%China: 22.4%India: 16.1%Japan: 7.0%6 others listed: 30.7%24%largest
United States427 · 23.8%China402 · 22.4%India290 · 16.1%Japan126 · 7.0%6 others listed552 · 30.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Amoebic Infections and Treatments research?

By volume in 2022–2025, Post Graduate Institute of Medical Education and Research publishes the most Amoebic Infections and Treatments research, followed by University of Tikrit and All India Institute of Medical Sciences.

By volume, 2022–2025

  1. 1 Post Graduate Institute of Medical Education and Research India 16 works
  2. 2 University of Tikrit Iraq 11 works
  3. 3 All India Institute of Medical Sciences India 11 works
  4. 4 Thi Qar University Iraq 9 works
  5. 5 Van Yüzüncü Yıl Üniversitesi Türkiye 9 works
  6. 6 Xinjiang Medical University China 8 works
  7. 7 Sağlık Bilimleri Üniversitesi Türkiye 8 works
  8. 8 Mohammed V University Morocco 8 works
  9. 9 Institute of Medical Sciences India 8 works
  10. 10 South China Agricultural University China 8 works

Who are the leading researchers in Amoebic Infections and Treatments?

The most-cited researchers publishing on Amoebic Infections and Treatments include Jaco J. Verweij.

  1. 1 Jaco J. Verweij 3.5k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Amoebic Infections and Treatments research done?

The largest centres of Amoebic Infections and Treatments research in 2022–2025 are Beijing (China), Mexico City (Mexico), Tokyo (Japan) and New Delhi (India).

Largest cities, 2022–2025

  1. 1 Beijing China 43 works
  2. 2 Mexico City Mexico 35 works
  3. 3 Tokyo Japan 33 works
  4. 4 New Delhi India 31 works
  5. 5 Paris France 27 works
  6. 6 Shanghai China 26 works
  7. 7 Tehran Iran 23 works
  8. 8 Guangzhou China 22 works
  9. 9 Istanbul Türkiye 21 works
  10. 10 Ürümqi China 21 works
See Amoebic Infections and Treatments on the map

Where is the best place to study Amoebic Infections and Treatments?

Among universities, judged by research, Post Graduate Institute of Medical Education and Research, Xinjiang Medical University and Thi Qar University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 6.6375%fractional works in this node (log) →share in the world top 10% →Post Graduate Institute of Medical Education and Research: 16, 5.2%Xinjiang Medical University: 8, 16.6%Thi Qar University: 9, 3.8%Van Yüzüncü Yıl Üniversitesi: 9, 3.2%University of Tikrit: 11, 0.0%Mohammed V University: 8, 6.1%All India Institute of Medical Sciences: 11, 8.4%Sağlık Bilimleri Üniversitesi: 8, 9.8%Xinjiang Medical Uni…Post Graduate Instit…Thi Qar UniversityVan Yüzüncü Yıl Üniv…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1Post Graduate Institute of Medical Education and Research India 70.55.2%16.3×16 +33.4%
2Xinjiang Medical University China 55.416.6%25.1×8 -31.1%
3Thi Qar University Iraq 48.53.8%20.1×9
4Van Yüzüncü Yıl Üniversitesi Türkiye 46.13.2%13.1×9 +25.8%
5University of Tikrit Iraq 41.30.0%14.1×11
6Mohammed V University Morocco 41.36.1%7.1×8 +26.1%
7All India Institute of Medical Sciences India 40.08.4%6.0×11 +14.4%
8Sağlık Bilimleri Üniversitesi Türkiye 33.79.8%5.0×8

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Amoebic Infections and Treatments research growing?

Output in 2018–2022 was 15% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Amoebic Infections and Treatments.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.